Thornburg Investment Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.48M Buy
83,190
+792
+1% +$50.3K 0.06% 103
2025
Q4
$5.24M Sell
82,398
-2,321
-3% -$144K 0.07% 125
2025
Q3
$4.66M Buy
84,719
+11,840
+16% +$488K 0.06% 129
2025
Q2
$2.41M Sell
72,879
-188,014
-72% -$6.54M 0.03% 149
2025
Q1
$105M Sell
260,893
-20,969
-7% -$964K 0.15% 87
2024
Q4
$13.3M Sell
281,862
-1,620
-0.6% -$84.1K 0.18% 86
2024
Q3
$15M Buy
283,482
+30,671
+12% +$1.71M 0.19% 76
2024
Q2
$13.7M Buy
252,811
+169,050
+202% +$10.2M 0.19% 78
2024
Q1
$5.87M Sell
83,761
-1,438
-2% -$111K 0.08% 147
2023
Q4
$7.11M Sell
85,199
-22,967
-21% -$832K 0.1% 126
2023
Q3
$3.19M Sell
108,166
-2,831
-3% -$94.3K 0.05% 158
2023
Q2
$3.62M Buy
110,997
+20,603
+23% +$762K 0.06% 151
2023
Q1
$3.18M Sell
90,394
-1,087
-1% -$44.3K 0.05% 152
2022
Q4
$4.19M Buy
91,481
+17,283
+23% +$744K 0.07% 153
2022
Q3
$3.6M Buy
+74,198
New +$3.57M 0.06% 160

Other funds holding CYTK